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Introduction

Zygomycosis refers to infectious disease variants caused by
Mucorales fungi species [1] . It may occur in progressive underlying risk profile patients such as immunosuppression, diabetic ketoacidosis, malignancies, extreme malnutrition, any conditions led to iron overload, burns, and trauma. Zygomycosis has a lifethreatening nature with multi-organ involvements such as cutaneous, pulmonary, and even neurologic invasions [2] . Thus, proper management and treatment of this multi-infection needs early detection of underlying risk factors along with medical and even surgical aggressive therapies. However, misdiagnosing identifiable risk factors is now a major problematic issue to improve disease progression and outcome [3, 4] . Moreover, because of identified different routes of infection such as inhalation of conidia, gastrointestinal ingestion (among malnourished patients), nonsterile tape and contaminated wooden splints, traumatic inoculation, and even via natural disasters [5] [6] [7] [8] [9] , the problem is compounded for disease control and treatment. Descriptions of zygomycosis appear to be increasing, perhaps given higher numbers of persons at risk [10] . Epidemiologically, the infection by zygomycosis has a worldwide distribution with no known gender, age, or interracial preferences; however some institutional studies have shown a gender tendency with a male-to-female ratio of 3:1 [11] . Regarding disease prognosis, the presence of some serious comorbidities and needing aggressive coordinated treatment strategies may potentially affect prognosis, however despite all efforts to identify disease risk factors as well as to control disease progress, zygomycosis may carry a mortality rate of 50-85% mostly due to its serious consequences including rhinocerebral and pulmonary events [12] [13] [14] . Unfortunately, no comprehensive reports have been published on epidemiological status of mucormycosis infections and its outcome in our population from 2007, Hence, the current study came to address epidemiological characteristics as well as clinical outcome of patients with mucormycosis infection referred to a referral hospital in Iran.
Methods
This retrospective study was performed at the Rasoul-e-Akram hospital, an 800-bed tertiary care teaching hospital in Tehran, Iran.
The pathology recorded charts were reviewed to identify all cases of Continuous variables were compared using t test or Mann-Whitney U test whenever the data did not appear to have normal distribution or when the assumption of equal variances was violated across the study groups. Categorical variables were, on the other hand, compared using chi-square test. The multivariable regression models were applied to determine indicators of disease outcome.
For the statistical analysis, the statistical software SPSS version 16.0 for windows (SPSS Inc., Chicago, IL) was used. P values of 0.05 or less were considered statistically significant.
Results
In total, 64 patients with Rhinocerebral zygomycosis were assessed. 
Discussion
As the first results and regarding demographic characteristics of our patients who suffered Rhinocerebral zygomycosis, we showed the prevalence of disease in an age wide spectrum from childhood to old adulthood. Also, men and women were similarly affected by this infection. Among underlying risk profiles, high prevalence of diabetes mellitus was revealed among patients that was shown in about two-third of them. Epidemiological studies showed high prevalence of diabetes mellitus in the patients in both developed and developing nations, however some clear differences were also revealed in the epidemiological aspects of disease between the nations that in developed countries, the disease remains uncommon and mostly occur in patients with diabetes mellitus and hematological malignancies, while in developing countries, zygormycosis has a sporadic pattern closely related to uncontrolled diabetes or trauma [18] [19] [20] . It seems that the relationship between high incidence rate of zygomycosis and diabetes is mainly influenced by uncontrolled situation of diabetes or occurring ketoacidosis as a serious predisposing factor for this infection. In total, reviewing the literature demonstrated the risky role of diabetes mellitus in 36% to 88% of patients [20] [21] [22] [23] [24] [25] .In contrast, controlling diabetes, proper management of ketoacidosis and the use of statins as a main treatment protocols for metabolic syndrome could effectively reduce the incidence of zygomycosis [26] [27] [28] . Sinuses involvement is a common clinical manifestations affecting disease poor prognosis.
This complication commonly appears as rhinocerebral mucormycosis, that is manifested by either sinusitis or periorbital cellulitis [29] . If untreated, sinusitis can spread from the sinuses and extend into the neighboring tissues such as orbit or orbital muscular complex leading to potential visual complications or may extend into the mouth and produce painful, necrotic ulcerations of the hard palate [30] . Another serious complication can be the spreading infection from sinus posteriorly to central nervous system and leading to cerebral vascular invasion and cerebral infarction, a serious cause for increasing disease-related mortality [31] . In our observation, 73.4% of patients suffered sinuses infections that mostly underwent invasive surgical procedure to prevent its progression. More importantly, the presence of sinusitis has been identified as an important predicting factor for early mortality in these patients leading to4.8 times more risk for mortality.
We saw an early mortality of 35% for affected patients with
Rhinocerebral zygomycosis that seems to be considerably high despite performing curative management in our center. Naturally, the early and long-term mortality following Rhinocerebral zygomycosis is strongly associated with the presence of underlying comorbidities. It has been shown that the overall mortality of pulmonary mucormycosis is approximately 50 to 70% [32, 33] .
Cutaneous and subcutaneous disease may lead to necrotizing fasciitis, which has a mortality approaching 80% [34, 35] . The mortality associated with dissemination to the brain approaches 100% [36] . In this regard, managing disease by proper antifungal agents leads to considerably decrease in mortality. It has been indicated that in cases with rhinocerebral mucormycosis, the mortality is about 70% in cases treated with antifungal agents alone versus 14% in cases treated with antifungal agents plus surgery [37, 38] . Similarly, in a combined series of rhinocerebral, cutaneous, and pulmonary mucormycosis, 65% of patients treated with surgery plus antifungal agents survived the infection, compared to none of the patients treated with antifungal agents alone [39] . Thus, the death rate is directly associated with whether the patients were
Page number not for citation purposes 4 managed medically or surgically. In our study, regardless of the type of comorbidity or treatment approach, high early mortality was reported following Rhinocerebral zygomycosis infection. However, as shown in our multivariable analysis, administrating antifungal treatment by high dose amphotericin, not only reduced in-hospital mortality, but also shortened hospital stay. However, it seems that the rate obtained for early mortality is notably high requiring deep assessment of its causes among our population.
Two underlying conditions including history of cancer and presence of neutropenia can adversely affect outcome of Rhinocerebral zygomycosis as shown in our analysis. It has been clearly shown that the overall mortality rate for Rhinocerebral zygomycosis remains higher than 50%, and it approaches 100% among patients with persistent neutropenia [32, 40] . In fact, the neutrophils are critical for inhibiting fungal spore proliferation and thus decrease in neutrophil count can predispose the patients to progressive
Rhinocerebral zygomycosis. The risky role of neutropenia is more prominent in patients with malignancies especially hematological cancers with immunosuppressive patterns. What is known about this topic 
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